Thanks RBx. Would be interested to know also so I don't attend next week in Brisbane. Obviously people were not impressed with CEP-1. I myself was only hoping the result would be really good but it it is another option to use with Chemo. Personally I thought CEP trial is good given the fact all these patients have exhausted other treatments and it extended a lot of patients for at least 6 months.
It is DARRT that I want to know how it is progressing. In July we might also know how Lupin is also progressing.
Briefing report, page-3
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.9¢ | $4.773K | 48.10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20574 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 38542 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
